Kyverna Therapeutics Financial Ratios for Analysis 2022-2024 | KYTX

Fifteen years of historical annual and quarterly financial ratios and margins for Kyverna Therapeutics (KYTX).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
3.054.45
-0.01-0.01
-0.01-0.02
-100.00
--418.28
--418.28
--403.32
--411.29
--411.29
-0.11
--
--
--
45.9439.05
45.9439.05
-80.28-43.17
46.2739.62
-105.12-73.48
-77.80-79.29
-78.73-80.97

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-06-302023-03-312022-12-31
14.8617.17----
0.000.00----
0.000.00----
------
------
------
------
------
------
------
------
------
------
-8.64-7.39----
-8.64-7.39----
-7.93-6.84----
-8.63-7.38----
7.738.37----
-1.15-1.070.00-36.17-12.440.00
-1.19-1.10--36.22-12.47-